Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.

MLA

Kaczanowska, Sabina, et al. “Immune Determinants of CAR-T Cell Expansion in Solid Tumor Patients Receiving GD2 CAR-T Cell Therapy.” Cancer Cell, vol. 42, no. 1, Jan. 2024, p. 35. EBSCOhost, https://doi.org/10.1016/j.ccell.2023.11.011.

APA

Kaczanowska, S., Murty, T., Alimadadi, A., Contreras, C. F., Duault, C., Subrahmanyam, P. B., Reynolds, W., Gutierrez, N. A., Baskar, R., Wu, C. J., Michor, F., Altreuter, J., Liu, Y., Jhaveri, A., Duong, V., Anbunathan, H., Ong, C., Zhang, H., Moravec, R., … Kaplan, R. N. (2024). Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy. Cancer Cell, 42(1), 35. https://doi.org/10.1016/j.ccell.2023.11.011

Chicago

Kaczanowska, Sabina, Tara Murty, Ahmad Alimadadi, Cristina F Contreras, Caroline Duault, Priyanka B Subrahmanyam, Warren Reynolds, et al. 2024. “Immune Determinants of CAR-T Cell Expansion in Solid Tumor Patients Receiving GD2 CAR-T Cell Therapy.” Cancer Cell 42 (1): 35. doi:10.1016/j.ccell.2023.11.011.